JFG
PHXM

Jefferies Financial Group’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Jefferies Financial Group’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-57,270
Closed -$189K – 2079
2022
Q4 		$189K Buy
+57,270
New +$336K ﹤0.01% 1310

Other funds holding PHXM

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Financial Group's PHXM Position: Q1 2023 in Review

Jefferies Financial Group sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q1 2023, closing a stake of 57,270 shares — an estimated $189K sold.

Jefferies Financial Group first reported a position in PHXM in Q4 2022 and held it in 1 quarter. The position peaked at $189K in Q4 2022. 9 funds tracked by Wall St. Rank hold PHXM as of Q1 2023.

  • Jefferies Financial Group reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 57,270 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q1 2023, an estimated $189K.
  • Jefferies Financial Group first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • Jefferies Financial Group's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $189K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q1 2023.

Based on Jefferies Financial Group's 13F filing for Q1 2023, filed 15 May 2023.